Commitments and Contingent Liabilities - Additional Information (Details) |
1 Months Ended | 3 Months Ended | |
|---|---|---|---|
|
Jan. 31, 2023
USD ($)
|
Mar. 31, 2026
USD ($)
|
Feb. 12, 2026
USD ($)
$ / shares
|
|
| Commitments And Contingencies [Line Items] | |||
| Potential material losses from claims, legal proceedings probable of occurring | $ 0 | ||
| Additional sought value for damages as part of requested modification | $ 66,000,000 | ||
| Avadel Pharmaceuticals Plc | |||
| Commitments And Contingencies [Line Items] | |||
| Contingent payments | $ 165,700,000 | ||
| Business combination, contingent consideration, additional cash payment per share | $ / shares | $ 1.5 | ||
| Avadel Pharmaceuticals Plc | Discount Rate | |||
| Commitments And Contingencies [Line Items] | |||
| Discount rate | 0.0547 |
| X | ||||||||||
- Definition Business combination, contingent consideration, additional cash payment per share. No definition available.
|
| X | ||||||||||
- Definition Commitments and contingencies. No definition available.
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Value of input used to measure liability in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|